Skip to main content
. 2022 Mar 22;11(7):1070. doi: 10.3390/cells11071070

Table 3.

Clinical trials evaluating the efficacy of anthocyanins on prostate cancer patients.

Population Number of Populations + Age Range Study Type Diet Source of Anthocyanin Anthocyanin Daily Dose Association between Anthocyanin Intake and CRC Risk Reference
Patients newly diagnosed with resectable prostate cancer 56 men/average age: 61.6 ± 1.02 years Interventional n.d Nectar of BRB 10 g BRB/day (8 men): 10 g BRB in 1 bottle
(total: 320 bottle)
n.a [93]
Nectar of BRB 20 g BRB/day (8 men): 20 g BRB in 1 bottle
(total: 320 bottle)
Confection of BRB 10 g BRB/day (8 men): 10 g BRB in 5 pieces (total: 1600 pieces)
Confection of BRB 20 g BRB/day (8 men): 20 g BRB in 10 pieces (total: 3200 pieces)
Patients receiving image guided intensity modulated radiation
therapy to their prostate, prostate and regional lymph nodes or prostate bed were included
41 men/average age: 68 years Observational Mostly New Zealand
European
cranberry (Vaccinium macrocarpo) capsules 1 capsule/day at breakfast during radiation therapy treatment, and
for 2 weeks post-treatment (9 weeks for prostate bed,
10 weeks for prostate and prostate nodes)
65% of patients taking cranberry capsules developed cystitis compared to the placebo group (90% patients) [94]
30% of patients taking cranberry capsules
Developed severe cystitis compared to the placebo group (45% patients)
None of them developed urinary tract infections
Patients receiving external beam radiation therapy to their prostate bed or prostate only and had not received previous pelvic radiation therapy 101 men/average age: 68 years (range 51–85) Observational Mostly New Zealand
European
cranberry (Vaccinium macrocarpo) capsules 2 capsules at breakfast during radiation therapy treatment,
For 2 weeks after
Three measurements of cystitis severity:
modified RTOG, O’Leary interstitial cystitis
scale, RICAS.
No significant differences were observed between cranberry treated and placebo groups
[95]

BRB: black raspberry (Rubus occidentalis), R TOG: radiation therapy oncology group grading, RICAS: novel radiation induced cystitis assessment scale, na: not analysed, n.d: not determined.